Regeneron Pharmaceuticals (REGN) Cash & Equivalents (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.99% |
| Dec 31, 2025 | 24.41% |
| Sep 30, 2025 | 25.58% |
| Jun 30, 2025 | -35.42% |
| Mar 31, 2025 | 24.19% |
| Dec 31, 2024 | 23.68% |
| Sep 30, 2024 | 4.74% |
| Jun 30, 2024 | -26.18% |
| Mar 31, 2024 | -4.69% |
| Dec 31, 2023 | 26.84% |
| Sep 30, 2023 | 11.10% |
| Jun 30, 2023 | -50.53% |
| Mar 31, 2023 | 26.09% |
| Dec 31, 2022 | -11.04% |
| Sep 30, 2022 | 2.83% |
| Jun 30, 2022 | 1.48% |
| Mar 31, 2022 | 15.94% |
| Dec 31, 2021 | -15.93% |
| Sep 30, 2021 | 65.64% |
| Jun 30, 2021 | 44.11% |
| Mar 31, 2021 | -34.45% |
| Dec 31, 2020 | 39.46% |
| Sep 30, 2020 | -21.04% |
| Jun 30, 2020 | -9.78% |
| Mar 31, 2020 | 36.49% |
| Dec 31, 2019 | 16.83% |
| Sep 30, 2019 | 32.45% |
| Jun 30, 2019 | -38.81% |
| Mar 31, 2019 | 16.41% |
| Dec 31, 2018 | 34.92% |
| Sep 30, 2018 | 18.51% |
| Jun 30, 2018 | -9.97% |
| Mar 31, 2018 | 25.45% |
| Dec 31, 2017 | 2.61% |
| Sep 30, 2017 | 6.42% |
| Jun 30, 2017 | -8.31% |
| Mar 31, 2017 | 51.68% |
| Dec 31, 2016 | -41.85% |
| Sep 30, 2016 | 42.36% |
| Jun 30, 2016 | 7.00% |
| Mar 31, 2016 | -25.32% |
| Dec 31, 2015 | 23.60% |
| Sep 30, 2015 | 67.60% |
| Jun 30, 2015 | -23.11% |
| Mar 31, 2015 | -21.71% |
| Dec 31, 2014 | 0.33% |
| Sep 30, 2014 | 7.73% |
| Jun 30, 2014 | 29.94% |
| Mar 31, 2014 | -13.77% |
| Dec 31, 2013 | 103.49% |
| Sep 30, 2013 | -31.04% |
| Jun 30, 2013 | 111.62% |
| Mar 31, 2013 | -21.68% |
| Dec 31, 2012 | 93.51% |
| Sep 30, 2012 | -30.79% |
| Jun 30, 2012 | -56.42% |
| Mar 31, 2012 | -18.41% |
| Dec 31, 2011 | 134.31% |
| Sep 30, 2011 | -18.84% |
| Jun 30, 2011 | 87.86% |
| Mar 31, 2011 | 20.26% |
| Dec 31, 2010 | -65.39% |
| Sep 30, 2010 | 190.43% |
| Jun 30, 2010 | -4.53% |
| Mar 31, 2010 | -43.35% |
| Dec 31, 2009 | -17.28% |
| Sep 30, 2009 | -7.79% |